Breakthrough COVID-19 infections and perceived vaccine effectiveness

被引:3
|
作者
Neely, Stephen R. [1 ]
Hao, Feng [2 ]
机构
[1] Univ S Florida, Sch Publ Affairs, 4202 E Fowler Ave,SOC 107, Tampa, FL 33620 USA
[2] Univ S Florida, Dept Sociol, 4202 E Fowler Ave,SOC 107, Tampa, FL 33620 USA
关键词
COVID-19; Breakthrough infections; Vaccine efficacy; Vaccine hesitancy;
D O I
10.1016/j.vaccine.2023.11.032
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: While SARS-CoV-2 vaccines provide significant protection against severe COVID-19 illness, breakthrough infections have sparked confusion among patients about the effectiveness of vaccination. It's unclear if (or to what extent) breakthrough infection experiences impact public perceptions of COVID-vaccine effectiveness, though the answer may have significant implications for public health communications and ongoing vaccine acceptance. Methods: We conducted a survey of 2,500 adults in the United States (February 27 - March 9, 2023) in order to better understand the relationship between breakthrough COVID-19 infections and perceived vaccine effectiveness. Survey respondents were selected using a stratified, quota sampling approach to ensure representativeness; analysis was conducted on responses from 1,928 participants who received a COVID-19 vaccine.Findings: Among those who tested positive for COVID-19 after being vaccinated, 21.18 % said that COVID-19 vaccines had been "less effective" than they initially expected, compared with 10.0 % of those who did not experience any breakthrough infections (X2 = 75.551; phi = 0.198; p <= 0.001). Those who experienced their own breakthrough infection were 1.37 times less likely to report perceived vaccine efficacy, while those whose family members experienced a breakthrough infection were 1.64 times less likely to report the same, ceteris paribus. The largest effect was observed among those who experienced both a personal and familial breakthrough infection. This group was almost two times less likely to describe COVID-19 vaccines as "very effective".Discussion: Breakthrough infections correlated with lower overall levels of perceived vaccine effectiveness, even after accounting for demographic and political considerations. Moving forward, public officials and health professionals should work proactively to ensure that breakthrough infections are understood in the broader context of overall vaccine effectiveness.
引用
收藏
页码:7689 / 7694
页数:6
相关论文
共 50 条
  • [1] COVID-19 vaccine breakthrough infections
    Gupta, Ravindra K.
    Topol, Eric J.
    [J]. SCIENCE, 2021, 374 (6575) : 1561 - 1562
  • [2] Hospitalisation among vaccine breakthrough COVID-19 infections
    Juthani, Prerak, V
    Gupta, Akash
    Borges, Kelly A.
    Price, Christina C.
    Lee, Alfred, I
    Won, Christine H.
    Chun, Hyung J.
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (11): : 1485 - 1486
  • [3] COVID-19 VACCINE BREAKTHROUGH INFECTIONS IN THE UNITED STATES, BY RACE
    Liu, M.
    Wong, A. C.
    McPheeters, J. T.
    Dixon, R.
    Madge, V
    Basra, G.
    Sachdev, A.
    Veeranki, P.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S448 - S449
  • [4] Predictors of death in COVID-19 vaccine breakthrough infections in Brazil
    Estofolete, Cassia Fernanda
    Fares, Gislaine Fusco
    Banho, Cecilia Artico
    Sacchetto, Livia
    Campos, Guilherme R. F.
    Queiroz, Flavia
    Mendes, Lina de Moura
    Machado Salomao, Maria Lucia
    Negri, Andreia Francesli
    Barcelos, Michela Dias
    Nogueira, Mauricio L.
    [J]. JOURNAL OF INFECTION, 2022, 84 (04) : E22 - E24
  • [5] Metabolic disorders, COVID-19 and vaccine-breakthrough infections
    Norbert Stefan
    [J]. Nature Reviews Endocrinology, 2022, 18 : 75 - 76
  • [6] Metabolic disorders, COVID-19 and vaccine-breakthrough infections
    Stefan, Norbert
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (02) : 75 - 76
  • [7] Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea
    Jang, Jieun
    Jeong, Hyopin
    Kim, Bong-Hwa
    An, Sura
    Yang, Hye-Ryun
    Kim, Sunjoo
    [J]. PLOS ONE, 2023, 18 (08):
  • [8] Is Measurement of Systemic IgG Antibodies the Wrong Way to Assess COVID-19 Vaccine Effectiveness for Breakthrough Infections?
    Levinson, Stanley S.
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (05): : 1242 - 1244
  • [9] Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan
    Rizwan, Wajiha
    Qureshi, Ahmad Uzair
    Rana, Muhammad Nasir
    Duggal, Mubeen Nazar
    Sohaib, Muhammad
    Sadiq, Masood
    [J]. ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2021, 27 (04): : 516 - 523
  • [10] Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
    Body, A.
    Ahern, E. S.
    Lal, L.
    Abdulla, H.
    Opat, S.
    Downie, P.
    Leahy, M.
    Fuentes-Bolanos, N.
    Padhye, B.
    Hamad, N.
    Milch, V.
    Segelov, E.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : 1544 - 1544